Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3967-3974

  Tsukui, Taku ^a,h   Hildesheim, Allan ^a   Schiffman, Mark H ^a   Lucci III, Joseph ^b   Contois, David ^a   Lawler, Patricia ^c   Rush, Brenda B ^c   Lorincz, Attila T ^d   Corrigan, Alice ^d   Burk, Robert D ^e   Qu, Weimin ^e   Marshall, Margaret A ^a   Mann, Dean ^f   Carrington, Mary ^f   Clerici, Mario ^a   Shearer, Gene M ^a   Carbone, David P ^b   Scott, David R ^c   Houghten, Richard A ^g   Berzofsky, Jay A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c KAISER PERMANENTE   (United States)

^d Digene Corporation   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^h NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; ONCOPROTEIN; VIRUS ANTIGEN; VIRUS DNA;

ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; FEMALE; FEMALE GENITAL TRACT INFECTION; HELPER CELL; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; TH1 CELLS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 9444268103     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Schiffman, M H. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl. Cancer Inst., 84: 394-398, 1992.
2. Bosch, F. X , Manos, M. M., Munoz, N , Sherman, M. E , Jansen, A., Peto, J., Schiffman, M. H., Moreno, V , and Shah, K. V. Prevalence of HPV DNA in cervical cancer in 22 countries J Natl. Cancer Inst., 87: 796-802, 1995
3. Shah, K V., and Howley, P. M. Papillomaviruses In: B. N. Fields, D M. Knipe, and P M. Howley (eds.), Fields Virology, pp 2077-2109. Philadelphia: Lippincott-Raven Publishers, 1996
4. Frazer, I. H., and Tindle, R W. Cell-mediated immunity to papillomaviruses. Papillomavirus Report, 3: 53-58, 1992
5. Brandsma, J. L. Animal models for HPV vaccine development. Papillomavirus Report, 5: 105-111, 1994.
6. Selvakumar, R., Borenstein, L. A , Lin, Y-L., Ahmed, R., and Wettstein, F O. Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J. Virol., 69: 602-605, 1995.
7. Benton, C., Shahidullah, H , and Hunter, J. A. A. Human papillomavirus in the immunosuppressed. Papillomavirus Report, 3: 23-26, 1992
8. Edwards, R. P., Kuykendall, K., Crowley-Nowick, P., Partridge, E. E., Shingleton, H. M., and Mestecky, J. T lymphocytes infiltrating advanced grades of cervical neoplasia: CD8-positive cells are recruited to invasion. Cancer (Phila), 76: 1411-1415, 1995.
9. Iwatsuki, K., Tagami, H , Takigawa, M., and Yamada, M Plane warts under spontaneous regression immunopathologic study on cellular constituents leading to the inflammatory reaction. Arch. Dermatol., 122: 655-659, 1986.
10. Suzich, J. A , Ghim, S-J., Palmer-Hill, F. J., White, W. I., Tamura, J K , Bell, J. A., Newsome, J. A., Jenson, A B., and Schlegel, R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl. Acad. Sci. USA, 92: 11553-11557, 1995.
11. Tay, S. K., Jenkins, D , Maddox, P , Campion, M., and Singer, A Subpopulations of Langerhans' cells in cervical neoplasia Br. J Obstet. Gynaecol., 94: 10-15, 1987.
12. Apple, R. J , Erlich, H. A., Klitz, W., Manos, M. M , Becker, T. M., and Wheeler, C. M HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet, 6: 157-162, 1994.
13. ∞03 and cervical intraepithelial neoplasia. Mol. Med., 1: 161-171, 1995.
14. Sher, A, Gazzinelli, R. T., Oswald, I. P., Clerici, M., Kullberg, M , Pearce, E J , Berzofsky, J. A., Mosmann, T. R., James, S. L., Morse, H C., III, and Shearer, G M. Role of T cell-derived cytokines in the down-regulation of immune responses in parasitic and retroviral infection. Immunol. Rev , 127: 183-204, 1992.
15. Bretscher, P A., Wei, G., Menon, J. N , and Bielefeldt-Ohmann, H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science (Washington DC), 257: 539-542, 1992.
16. Heinzel, F P., Schoenhaut, D. S., Rerko, R. M., Rosser, L E, and Gately, M. K. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp Med., 177: 1505-1509, 1993.
17. Sypek, J. P , Chung, C L , Mayor, S. E. H., Subramanyam, J. M., Goldman, S J , Sieburth, D. S., Wolf, S. F., and Schaub, R G Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med., 177: 1797-1802, 1993
18. Afonso, L C. C., Scharton, T. M., Vieira, L. Q , Wysocka, M., Trinchieri, G , and Scott, P The adjuvant effect of interleukin 12 in a vaccine against Leishmania major, Science (Washington DC), 263: 235-237, 1994.
19. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA, 90: 948-952, 1993
20. Romagnani, S. Human Th1 and Th2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch. Allergy Immunol., 98: 279-285, 1992
21. Locksley, R M Interleukin 12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA, 90: 5879-5880, 1993.
22. Finkelman, F. D , Madden, K. B , Cheever, A. W , Katona, I M., Morris, S. C , Gately, M. K., Hubbard, B. R., Cause, W C, and Urban, J. F, Jr. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites J. Exp. Med , 179: 1563-1572, 1994.
23. Yamamura, M , Uyemura, K., Deans, R. J , Weinberg, K , Rea, T. H., Bloom, B. R., and Modlin, R. L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (Washington DC), 254, 277-279, 1991.
24. Hilleman, M R. Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS. AIDS Res. Hum. Retroviruses, 10: 3-12, 1994.
25. Clerici, M., and Shearer, G. M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today, 15 575-581, 1994.
26. Wilczynski, S. P., Pearlman, L , and Walker, J Identification of HPV-16 early genes retained in cervical carcinomas. Virology, 166: 624-627, 1988.
27. Yee, C., Krishnan-Hewlett, I., Baker, C. C , Schlegel, R., and Howley, P M Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines Am. J Pathol., 119: 361-366, 1985.
28. Schneider-Maunoury, S , Croissant, O., and Orth, G. Integration of human papillomavirus type 16 DNA sequences, a possible early event in the progression of genital tumors. J Virol , 61: 3295-3298, 1987
29. Schiffman, M. H., Bauer, H M., Hoover, R N., Glass, A G., Cadell, D M, Rush, B B., Scott, D. R., Sherman, M. E., Kurman, R. J , Wacholder, S., Stanton, C K, and Manos, M. M Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst , 85: 958-964, 1993
30. IARC Epidemiology of infection. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Human Papillomaviruses, pp 60-65 Lyon, France IARC, 1995
31. Cason, J., Kaye, J. N , and Best, J M. Nonsexual acquisition of human genital papillomaviruses. Papillomavirus Report, 6 1-7, 1995
32. Houghten, R. A General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl Acad. Sci. USA, 82: 5131-5135, 1985.
33. Seedorf, K., Krammer, G., Durst, M., Suhai, S , and Röwekamp, W G Human papillomavirus type 16 DNA sequence. Virology, 145: 181-185, 1985.
34. Clerici, M., Stocks, N I., Zajac, R. A , Boswell, R. N., Bernstein, D. C., Mann, D. L., Shearer, G M., and Berzofsky, J A. Interleukin 2 production used to detect antigenic peptide recognition by T helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature (Lond), 339: 383-385, 1989.
35. Clerici, M., Stocks, N I., Zajac, R. A., Boswell, R N , Lucey, D. R., Via, C. S., and Shearer, G. M. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic HIV-seropositive patients, independence of CD4 cell numbers and clinical staging. J. Clin. Invest., 84: 1892-1899, 1989.
36. Schiffman, M. H., Kiviat, N. B., Burk, R. D., Shah, K. V , Daniel, R W., Lewis, R , Kuypers, J., Manos, M. M , Scott, D R, Sherman, M. E., Kurman, R J , Stoler, M. H , Glass, A G., Rush, B. B., Mielzynska, I , and Lonncz, A T. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin. Microbiol., 33: 545-550, 1995
37. Resnick, R M., Cornelissen, M. T. E., Wright, D. K., Eichinger, G H., Fox, H. S., ter Schegger, J., and Manos, M M. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst., 82: 1477-1484, 1990.
38. Jacobs, M. V., de Roda Husman, A. M , Van Den Brule, A. J C., Snijders, P. J., Meijer, C. J L M., and Walboomers, J. M. M. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol., 33: 901-905, 1995.
39. Tachezy, R , Van Ranst, M. A., Cruz, Y., and Burk, R. D. Analysis of short novel human papillomavirus sequences. Biochem. Biophys. Res Commun , 204: 820-827, 1994
40. Lorincz, A. T., Reid, R , Jenson, A B , Greenberg, M. D., Lancaster, W., and Kurman, R. J Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types Obstet. Gynecol., 79: 328-337, 1992.
41. Kadish, A S , Romney, S. L , Ledwidge, R., Tindle, R., Fernando, G J P , Zee, S. Y., Van Ranst, M. A., and Burk, R D. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. J. Gen Virol., 75: 2277-2284, 1994.
42. Mosmann, T. R , and Moore, K. W The role of IL-10 in cross-regulation of Th1 and Th2 responses. Immunol. Today, 12: 49-53, 1991.
43. + lymphocytes. Transplantation (Baltimore), 55 1349-1355, 1993.
44. + and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells. Transplantation (Baltimore), 55: 1356-1361, 1993.
45. Monach, P. A , Meredith, S. C., Siegel, C T , and Schreiber, H A unique tumor antigen produced by a single amino acid substitution. Immunity, 2: 45-59, 1995.
46. Topalian, S. L., Muul, L., Solomon, D., and Rosenberg, S. A. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J Immunol Methods, 102: 127-141, 1987
47. Clerici, M., Ferrario, E , Trabattoni, D , Viviani, S , Bonfanti, V , Venzon, D. J., Clerici, E., Shearer, G. M., and Villa, M. L. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease. Eur. J Cancer, 30: 1464-1470, 1994.
48. Rook, A. H , Kubin, M., Cassin, M , Vonderheid, E. C., Vowels, B R., Wolfe, J T , Wolf, S. F., Singh, A., Trinchieri, G., and Lessin, S. R. IL-12 reverses cytokine and immune abnormalities in Sézary syndrome. J. Immunol., 154: 1491-1498, 1995.
49. Tendler, C. L., Burton, J D , Jaffe, J, Danielpour, D., Charley, M., McCoy, J P., Pittelkow, M R , and Waldmann, T. A. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res., 54: 4430-4435, 1994.
50. Vowels, B. R., Cassin, M., Vonderheid, E C , and Rook, A. H. Aberrant cytokine production by Sézary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J. Invest. Dermatol., 99: 90-94, 1992.
51. Stem, L. J., and Wiley, D. C, Antigenic peptide binding by class I and class II histocompatibility proteins. Structure (Lond.), 2: 245-251, 1994.
52. Clerici, M., Hakim, F. T., Venzon, D. J , Blatt, S., Hendrix, C. W., Wynn, T. A , and Shearer, G M. Changes in interleukin 2 and interleukin 4 production in asymptomatic HIV-seropositive individuals. J. Clin. Invest., 91: 759-765, 1993.
53. Romagnani, S. Human Th1 and Th2 subsets: doubt no more. Immunol. Today, 12: 256-257, 1991.
54. Ben-Sasson, S. Z., Le Gros, G., Conrad, D. H., Finkelman, F. D., and Paul, W. E. IL-4 production by T cells from naive donors: IL-2 is required for IL-4 production. J Immunol., 145: 1127-1136, 1990.